← Back to Patent Explorer
US5407793A Expired / Lapsed US ⏱️ 0.0 years remaining

An aqueous heart preservation and cardioplegia solution

Assignee: University of Pittsburgh
•
Filing: 1993-06-18
•
Granted: 1995-04-18
•
Expires: 2013-06-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for preserving a patient's organ for transplantation and cardioplegia during cardiac surgery is disclosed which includes harvesting the patient's organ for transplantation or arresting the heart during cardiac surgery, perfusing the organ or heart with an aqueous solution, and removing at least a substantial portion of the aqueous solution from the organ or heart to effect the removal of waste products from the organ before transplantation or restarting the heart. The aqueous solutions of these inventions promote anaerobic glycolysis, remove waste products from the organ and maintain the energy production capacity of the organ and are preferably comprised of about 50 to 150 millimoles of histidine per liter of the solution, at least one energy providing material for maintaining the energy production capacity of the organ, about 60 to 90 millimoles of Na+ per liter of the solution, about 10 to 25 millimoles of K+ per liter of the solution, and about 3 to 8 millimoles of adenosine per liter of the solution for the transplantation solution and 0.001 to 1 millimoles of adenosine per liter of the solution for cardioplegia. Sodium entry into and depolarization of the cells is resisted by the extracellular to intracellular sodium gradient and use of adenosine. The aqueous solutions of this invention have a pH of about 6.8 to 8.0 where intracellular pH is maintained by the buffering action of the histidine and the solution is preferably used at moderate hypothermia for up to 24 hours.

Inventors

  • 👤 Pedro J. Del Nido
  • 👤 Hung Cao-Danh
  • 👤 K. Eric Sommers
  • 👤 Akihiko Ohkado

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 18:31
CPC Classifications
A; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/126

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 131 words
An aqueous heart preservation solution consisting essentially of: about 50 to 150 millimoles of histidine per liter of said solution; at least one energy providing material for maintaining energy production capacity of the organ; about 20 to 120 millimoles of Na + per liter of said solution; about 5 to 30 millimoles of K + per liter of said solution; about 1 to 10 millimoles of adenosine per liter of said solution; about 1 to 20 units of regular insulin per liter of said solution: and about 100 milligrams of lidocaine per liter of said solution wherein said heart preservation solution promotes anaerobic glycolysis, removes waste products from the organ by buffering, maintains the energy production capacity of the organ, and resists sodium entry into the cell during ischemia and reperfusion.
Claim 2
Dependent Claim 131 words
An aqueous heart preservation solution consisting essentially of: about 50 to 150 millimoles of histidine per liter of said solution; at least one energy providing material for maintaining energy production capacity of the organ; about 20 to 120 millimoles of Na + per liter of said solution; about 5 to 30 millimoles of K + per liter of said solution; about 1 to 10 millimoles of adenosine per liter of said solution; about 1 to 20 units of regular insulin per liter of said solution: and about 100 milligrams of lidocaine per liter of said solution wherein said heart preservation solution promotes anaerobic glycolysis, removes waste products from the organ by buffering, maintains the energy production capacity of the organ, and resists sodium entry into the cell during ischemia and reperfusion.
Claim 3
Dependent Claim 52 words
The aqueous solution of claim 1, wherein the amount of said Na + is about 60 to 90 millimoles per liter of said solution; said K + is about 10 to 25 millimoles per liter of said solution; and said adenosine is about 3 to 8 millimoles per liter of said solution.
Claim 4
Dependent Claim 18 words
The aqueous solution of claim 2, wherein said solution has a pH of about 6.8 to about 8.0.
Claim 5
Dependent Claim 34 words
The aqueous solution of claim 3, wherein said energy providing material comprises about 5 to 20 millimoles of glucose per liter of said solution, whereby anaerobic glycolysis is promoted by use of said glucose.
Claim 6
Dependent Claim 34 words
The aqueous solution of claim 3, wherein said energy providing material comprises about 5 to 20 millimoles of fructose per liter of said solution, whereby anaerobic glycolysis is promoted by use of said fructose.
Claim 7
Dependent Claim 64 words
The aqueous solution of claim 4, wherein said solution further includes: about 4 to 16 millimoles of Mg +2 per liter of said solution; about 0.05 to 1.0 millimoles of Ca +2 per liter of said solution; about 1.0 to 5.0 millimoles of PO 4 -3 per liter of said solution; and about 10 to 20 millimoles of mannitol per liter of said solution.
Claim 8
Dependent Claim 54 words
The aqueous solution of claim 6, wherein the amount of said Mg +2 is about 4 to 8 millimoles per liter of said solution; said Ca +2 is about 0.05 to 0.4 millimoles per liter of said solution; and said PO 4 -3 is about 1.25 to 3.0 millimoles per liter of said solution.
Claim 9
Dependent Claim 14 words
The aqueous solution of claim 7, wherein said aqueous solution further includes sterile water.
Claim 10
Dependent Claim 13 words
The aqueous solution of claim 8, wherein said solution further includes an antiseptic.
Claim 11
Dependent Claim 13 words
The aqueous solution of claim 8, wherein said solution further includes an antibiotic.
Claim 12
Dependent Claim 131 words
An aqueous cardioplegia solution consisting essentially of: about 50 to 150 millimoles of histidine per liter of said solution; at least one energy providing material for maintaining energy production capacity of the heart; about 20 to 120 millimoles of Na + per liter of said solution; about 5 to 30 millimoles of K + per liter of said solution; about 0.001 to 1 millimole of adenosine per liter of said solution; about 1 to 20 units of regular insulin per liter of said solution; and about 100 milligrams of lidocaine per liter of said solution wherein said aqueous solution for cardioplegia promotes anaerobic glycolysis, removes waste products from the organ by buffering, maintains the energy production capacity of the organ, and resists sodium entry into the cell during ischemia and reperfusion.
Claim 13
Dependent Claim 131 words
An aqueous cardioplegia solution consisting essentially of: about 50 to 150 millimoles of histidine per liter of said solution; at least one energy providing material for maintaining energy production capacity of the heart; about 20 to 120 millimoles of Na + per liter of said solution; about 5 to 30 millimoles of K + per liter of said solution; about 0.001 to 1 millimole of adenosine per liter of said solution; about 1 to 20 units of regular insulin per liter of said solution; and about 100 milligrams of lidocaine per liter of said solution wherein said aqueous solution for cardioplegia promotes anaerobic glycolysis, removes waste products from the organ by buffering, maintains the energy production capacity of the organ, and resists sodium entry into the cell during ischemia and reperfusion.
Claim 14
Dependent Claim 39 words
The aqueous solution of claim 11; wherein the amount of said Na + is about 60 to 90 millimoles per liter of said solution; and said K + is about 10 to 25 millimoles per liter of said solution.
Claim 15
Dependent Claim 18 words
The aqueous solution of claim 12, wherein said solution has a pH of about 6.8 to about 8.0.
Claim 16
Dependent Claim 32 words
The aqueous solution of claim 13, wherein said energy providing material comprises about 5 to 20 millimoles of glucose per liter of said solution, whereby anaerobic glycolysis is promoted by said glucose.
Claim 17
Dependent Claim 32 words
The aqueous solution of claim 13, wherein said energy providing material comprises about 5 to 20 millimoles of fructose per liter of said solution, whereby anaerobic glycolysis is promoted by said fructose.
Claim 18
Dependent Claim 64 words
The aqueous solution of claim 14, wherein said solution further includes: about 4 to 16 millimoles of Mg +2 per liter of said solution; about 0.05 to 0.4 millimoles of Ca +2 per liter of said solution; about 1.0 to 5.0 millimoles of PO 4 -3 per liter of said solution; and about 10 to 20 millimoles of mannitol per liter of said solution.
Claim 19
Dependent Claim 54 words
The aqueous solution of claim 16, wherein the amount of said Mg +2 is about 4 to 8 millimoles per liter of said solution; said Ca +2 is about 0.05 to 0.4 millimoles per liter of said solution; and said PO 4 -3 is about 1.25 to 3.0 millimoles per liter of said solution.
Claim 20
Dependent Claim 14 words
The aqueous solution of claim 16, wherein said aqueous solution further includes sterile water.
Claim 21
Dependent Claim 13 words
The aqueous solution of claim 18, wherein said solution further includes an antiseptic.
Claim 22
Dependent Claim 13 words
The aqueous solution of claim 18, wherein said solution further includes an antibiotic.

References Cited (Backward Citations)

SU878297A1 Cited
US4981691A Cited
US4415556A Cited
US4663289A Cited
US4798824A Cited
US4873230A Cited
US4920044A Cited
US5082831A Cited
US5145771A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-04-17 1998-10-17 1999-04-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-04-17 2002-10-17 2003-04-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-04-17 2006-10-17 2007-04-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag